Enliven Therapeutics, Inc. · NASDAQ:ELVN

Commodore Capital LP reported a 9.90% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Commodore Capital LP reported a 9.90% stake in Enliven Therapeutics, Inc., 6,022,957 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
6,022,957
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%6,022,957
Commodore Capital Master LP9.90%6,022,957
Robert Egen Atkinson9.90%6,022,957
Michael Kramarz9.90%6,022,957

Source

View original at SEC

Related